Thomas J. Hook was appointed President and CEO of Barnes effective July 14, 2022. Mr. Hook previously served as Chief Executive Officer and Director of SaniSure, Inc., a global leader in the design and manufacturing of single-use systems and components for drug and vaccine manufacturing and other biotech applications. Mr. Hook was appointed to the Barnes Board of Directors in 2016 and previously served on the Audit Committee and Corporate Governance Committee. He currently serves as a Director of NeuroNexus Inc. Mr. Hook previously served as Chief Executive Officer of Q Holding Company and President and Chief Executive Officer and Chief Operating Officer of Integer (formerly Greatbatch), and previously held leadership positions at CTI Molecular Imaging and General Electric Medical Systems. His prior experience also includes service as Chairman of the Board and member of the Executive Committee of HealthNow New York, Inc., and as a Director of Tactiva Therapeutics, Inc. Mr. Hook started his career as a Nuclear Engineer in the U.S. Navy.